In Oct. 2019, the Texas Prescription Monitoring Program identified itself as a clinical data registry for the Public Health and Clinical Data Registry Reporting objective in the Texas Medicaid Electronic Health Record Incentive/Promoting Interoperability Program. Eligible professionals participating in the Texas Medicaid EHR Incentive/PI Program who are registered and conduct queries of patient prescription history with the PMP’s AWARxE system can use the PMP to attest to the clinical data registry reporting measure in Program Year 2019 and beyond.
The Texas PMP, maintained by the Texas State Board of Pharmacy, collects and monitors prescription data for controlled substances dispensed by Texas pharmacies or to Texas residents. The PMP AWAReX database allows registered providers to search a patient’s history of controlled substance prescriptions to inform prescribing practices and help prevent prescription drug misuse.
Beginning in March 2020 prescribers will be required to check the PMP before issuing any prescription for opioids, benzodiazepines, barbiturates or carisoprodol.